A review and recommendations for oral chaperone therapy in adult patients with Fabry disease.

Abstract excerpt

Fabry disease (FD) is a rare, X-linked lysosomal storage disorder affecting both males and females caused by genetic abnormalities in the gene encoding the enzyme α-galactosidase A. FD-affected patients represent a highly variable clinical course with first symptoms already appearing in young age. The disease causes a progressive multiple organ dysfunction affecting mostly the heart, kidneys and nervous system,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 1-Deoxynojirimycin
• Share to alpha-Galactosidase